Concepedia

Akira Nishijima

AN

Statistics

Publications

8

Citations

169

H-Index

8

Active since

2016

Affiliations

The University of Tokyo(Current)

Saitama Medical University

Nihon University

University of Tokyo Hospital

Akira Nishijima is an author at The University of Tokyo specializing in cell biology, medicine, and ovarian cancer.

ORCID

Top concepts

Publications per year

2016–2024

8

Publications

8

MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53

Chinami Makii, Katsutoshi Oda, Yuji Ikeda et al. · Oncotarget · 2016 · 42 citations · Full text

The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma

Hirokazu Matsushita, Kosei Hasegawa, Katsutoshi Oda et al. · OncoImmunology · 2017 · 27 citations · Full text

Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma

Hirokazu Matsushita, Kosei Hasegawa, Katsutoshi Oda et al. · Journal for ImmunoTherapy of Cancer · 2020 · 23 citations · Full text

The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway

Juri Ogishima, Ayumi Taguchi, Akira Kawata et al. · BMC Cancer · 2018 · 22 citations · Full text

Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma

Chinami Makii, Yuji Ikeda, Katsutoshi Oda et al. · Gynecologic Oncology · 2019 · 16 citations

, , +6

1–5 of 8